Drug Discovery AI Talk
By Dr. Jake Chen
Listen to a podcast, please open Podcast Republic app. Available on Google Play Store and Apple App Store.
Image by Dr. Jake Chen
Category: Tech News
Open in Apple Podcasts
Open RSS feed
Open Website
Rate for this podcast
Subscribers: 1
Reviews: 0
Episodes: 75
Description
Late-breaking advances in AI-enabled drug discovery, including news, research progress, market trends, and interviews
| Episode | Date |
|---|---|
|
#75. The AI Patent Landscape 2026
|
Sep 25, 2026 |
|
#74. Is Drug Discovery AI Safe?
|
Sep 18, 2026 |
|
#73. The Triumph of Daraxonrasib
|
Sep 11, 2026 |
|
#72. 2026 Emerging Trends
|
Sep 04, 2026 |
|
#71. Magic Wands
|
Aug 28, 2026 |
|
#70. Beyond AlphaFold
|
Aug 24, 2026 |
|
#69. CollaboFest
|
Aug 07, 2026 |
|
#68. Molecular Glues in Therapy
|
Jul 31, 2026 |
|
#67. Does Size Matter?
|
Jul 24, 2026 |
|
#66. Quantitative Systems Pharmacology
|
Jul 17, 2026 |
|
#65. Orbiting around Big Pharma
|
Jul 10, 2026 |
|
#64. Foundation Models
|
Jul 03, 2026 |
|
#63. The Era of NAMs
|
Jun 26, 2026 |
|
#62. Predicting Toxicity
|
Jun 19, 2026 |
|
#61. AI Era Evidence Flywheel
|
Jun 12, 2026 |
|
#60. Cracking the "Undruggable" Target
|
Jun 06, 2026 |
|
#59. Drug Discovery AI Teammates
|
May 29, 2026 |
|
#58. Do We Need Mavericks?
|
May 22, 2026 |
|
#57. Do You Turst your AI?
|
May 15, 2026 |
|
#56. Ethics in AI for Drug Discovery
|
May 08, 2026 |
|
#55. AI for Drug Patents
|
May 02, 2026 |
|
#54. Companion Diagnostic Biomarkers
|
Apr 17, 2026 |
|
#53. The Math of AI Drug Discovery
|
Apr 10, 2026 |
|
#52. Benchmarking AI for Drug Discovery
|
Apr 03, 2026 |
|
#51. OpenClaw for BioPharma
|
Mar 13, 2026 |
|
#50. Atomic Level Drug Design
|
Mar 06, 2026 |
|
#49. From Prompts to Drugs
|
Feb 28, 2026 |
|
#48. Virtual Clinical Trials
|
Feb 20, 2026 |
|
#47. The Silicon Alchemist
|
Feb 13, 2026 |
|
#46. Top Ten AI Research Papers in 2025
|
Feb 06, 2026 |
|
#45. Genome-wide Virtual Screening
|
Jan 16, 2026 |
|
#44. Modern Drug Delivery Platforms
|
Jan 02, 2026 |
|
#43. Antibody-Drug Conjugate
|
Dec 26, 2025 |
|
#42. Biologic Immunogenecity
|
Dec 19, 2025 |
|
#41. CAR T Cell Therapy
|
Dec 14, 2025 |
|
#40. AI-Guided Alzheimer's Trial Design Lessons
|
Dec 05, 2025 |
|
#39. AI Drug Discovery Career Roadmap: Anti-Fragile Skills
|
Nov 29, 2025 |
|
#38. US and China Rivalry
|
Nov 22, 2025 |
|
#37. Open Source Drug Discovery 2.0
|
Nov 14, 2025 |
|
#36. Future of IND Filings
|
Nov 07, 2025 |
|
#35. AI-Driven Drug Repurposing
|
Oct 31, 2025 |
|
#34. AI Agents Transform Drug Discovery
|
Oct 24, 2025 |
|
#33. Modern Therapeutic Modalities
|
Oct 17, 2025 |
|
#32. AI Drug Discovery Startups
|
Oct 10, 2025 |
|
#31. Neuroendocrine Peptide Analogs
|
Oct 03, 2025 |
|
#30. Autism Data Science Initiative: Unlocking Precision Treatment
|
Sep 26, 2025 |
|
#29. Cystic Fibrosis: A Blueprint for Rare Disease Cures
|
Sep 19, 2025 |
|
#28. Eroom's Law
|
Sep 12, 2025 |
|
#27. Druggability and AI
|
Sep 05, 2025 |
|
#26. AI for Combination Drug Therapy
|
Aug 29, 2025 |
|
#25. Overall Survival Focus and AI Oncology Drugs
|
Aug 22, 2025 |
|
#24. Digital Twins: Transforming Clinical Trials
|
Aug 08, 2025 |
|
#23. AI and the Decentralization of Drug Discovery
|
Aug 01, 2025 |
|
#22. Molecular Glue Degraders
|
Jul 25, 2025 |
|
#21. N-of-1: the Future of Personalized Drug Development
|
Jul 18, 2025 |
|
#20. Ensifentrine's Triumph: An AI Blueprint for Drug Development
|
Jul 11, 2025 |
|
#19. AI Agents: Transforming Drug Discovery through Collaborative Partnerships
|
Jul 04, 2025 |
|
#18. First-in-Class vs. Best-in-Class AI Drug Discovery Strategies
|
Jun 27, 2025 |
|
#17. Atul Butte: Pioneer of Data-Driven Medicine
|
Jun 20, 2025 |
|
#16. Can AI scientists revolutionize drug discovery?
|
Jun 13, 2025 |
|
#15. AAV 2.0: Next-Generation Gene Therapy Vectors
|
Jun 06, 2025 |
|
#14. Global Trial & Error: Can AI Help? (05/30/2025)
|
May 30, 2025 |
|
#13. Chemical Space Docking: Is Bigger Better? (05/23/2025)
|
May 23, 2025 |
|
#12. Can AI help develop the next-generation diabetes drug? (05/16/2025)
|
May 16, 2025 |
|
#11. TYK2 Inhibitor Landscape and Pipeline (05/09/2025)
|
May 09, 2025 |
|
#10. Biomedical Research Funding and Innovation: May 2025 Senate Appropriation Committee Hearing (05/06/2025)
|
May 06, 2025 |
|
#9. Patent Dispute and Protections in the New AI Era (05/02/2025)
|
May 02, 2025 |
|
#8. Immune Response, Vaccines, and Autism: An Unbiased Scientific Review (04/25/2025)
|
Apr 25, 2025 |
|
#7. FDA Roadmap: Reducing Animal Testing in Preclinical Studies (04/22/2025)
|
Apr 23, 2025 |
|
#3. FDA Guidance: AI in Drug and Biological Product Regulatory Decisions (01/30/2025)
|
Apr 22, 2025 |
|
#2. 2024 Fierce 50: Innovations and Breakthroughs in Biopharma (01/01/2025)
|
Apr 22, 2025 |
|
#5. GLP-1 Medications: Current Status and Future Metabolic Therapies (03/15/2025)
|
Apr 22, 2025 |
|
#1. AI Drug Discovery in 2025: Trump, Kennedy, and Health Policy Outlook (11/14/2024)
|
Apr 22, 2025 |
|
#4. Alzheimer's Drug Development: Mechanisms, IP, and the Evolving Landscape (02/10/2025)
|
Apr 22, 2025 |
|
#6. AI in Drug Discovery - Reality Check (04/21/2025)
|
Apr 22, 2025 |